Characterization and quantification of fluoxymesterone metabolite in horse urine by gas chromatography/mass spectrometry.
Masayuki Yamada, Sugako Aramaki, Tomoo Hosoe, Masahiko Kurosawa, Isao Kijima-Suda, Koichi Saito, Hiroyuki Nakazawa
Index: Anal. Sci. 24(7) , 911-4, (2008)
Full Text: HTML
Abstract
Fluoxymesterone, an anabolic steroid with the 17alpha-methyl,17beta-hydroxy group, has been developed as an oral formulation for therapeutic purposes. However, it is also used illegally in racehorses to enhance racing performance. In this study, we detected 9alpha-fluoro-17,17-dimethyl-18-norandrostane-4,13-dien-11beta-ol-3-one by gas chromatography/mass spectrometry (GC/MS), which has not been reported as a fluoxymesterone metabolite so far in horse. It was synthesized for use as a reference standard, and characterized on the basis of (1)H NMR and (13)C NMR spectra, as well as GC/MS EI mass spectra of TMS derivatives. It was excreted as the main metabolite in horse urine, and its reference standard could be synthesized easily. Therefore, this metabolite could be a useful target for a doping test of fluoxymesterone in racehorses.
Related Compounds
Related Articles:
Rat liver lysosomal and mitochondrial activities are modified by anabolic-androgenic steroids.
1999-02-01
[Med. Sci Sports Exerc. 31 , 243, (1999)]
1997-12-19
[J. Chromatogr. B. Biomed. Sci. Appl. 704 , 119, (1997)]
2000-01-01
[J. Clin. Oncol. 18(2) , 262-6, (2000)]
Sample size calculations for the two-sample problem using the multiplicative intensity model.
2001-02-28
[Stat. Med. 20(4) , 557-79, (2001)]
Toxic effects of anabolic-androgenic steroids in primary rat hepatic cell cultures.
1995-08-01
[J. Pharmacol. Toxicol. Methods 33(4) , 187-95, (1995)]